After scrapped IPO, Pulmonx raises $66M to back minimally …

 
AUTOMATED NEWS ALERT

After scrapped IPO, Pulmonx raises $66M to back minimally …

Chronic obstructive pulmonary disease (COPD) is one of the most dangerous comorbidities for COVID-19 patients – as well as a major cause of death that predates the current pandemic. Pulmonx Corp. has …

Read the full article by following the link below:
Go to Source

*This Automated News Alert is brought to you by DIGITAL BUSINESS JOURNAL™ alongside top analyses on digital business sector. We are scanning large amounts of data from various business sources and select the most relevant headlines providing the reader with a comprehensive & updated outlook.